Takeda makes $61 billion bid for drugmaker Shire: sources

Takeda Pharmaceutical (4502.T) has made a bid for Shire (SHP.L) that values the London-listed drugmaker at around $61 billion, two sources with direct knowledge of the matter told Reuters.